Q2 2016 13F Holders as of 6/30/2016
-
Type / Class
-
Equity / Ordinary shares, par value $0.0001 per share
-
Shares outstanding
-
1.39B
-
Number of holders
-
38
-
Total 13F shares, excl. options
-
8.28M
-
Shares change
-
+567K
-
Total reported value, excl. options
-
$241M
-
Value change
-
+$17M
-
Number of buys
-
17
-
Number of sells
-
-13
-
Price
-
$29.80
Significant Holders of BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) as of Q2 2016
46 filings reported holding ONC - BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share as of Q2 2016.
BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) has 38 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.28M shares
of 1.39B outstanding shares and own 0.6% of the company stock.
Largest 10 shareholders include FMR LLC (2.3M shares), BAKER BROS. ADVISORS LP (1.91M shares), Hillhouse Capital Management, Ltd. (700K shares), Boxer Capital, LLC (494K shares), PRICE T ROWE ASSOCIATES INC /MD/ (454K shares), Temasek Holdings (Private) Ltd (380K shares), Rock Springs Capital Management LP (225K shares), TD ASSET MANAGEMENT INC (203K shares), EcoR1 Capital, LLC (175K shares), and QVT Financial LP (170K shares).
This table shows the top 38 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.